Use of HRV Measuring Hearing-aid Device to Detect Acute Stress
1 other identifier
interventional
30
1 country
1
Brief Summary
Validation of in-ear device to measure acute mental stress in comparison with a Polar H10 chest band. Stress is measured on the basis of heart rate variability.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2022
CompletedFirst Submitted
Initial submission to the registry
August 1, 2022
CompletedFirst Posted
Study publicly available on registry
August 3, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2022
CompletedAugust 4, 2022
August 1, 2022
3 months
August 1, 2022
August 2, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Heart rate variability measured BIOMETRIC in-ear device
RMSSD
1 day
Study Arms (1)
Intervention
EXPERIMENTALInterventions
Wearing BIORICS in their ear and perform mental arrhythmic test, relaxation exercises and Stroop test
Eligibility Criteria
You may qualify if:
- Dutch speaking and understanding
- Evidence of a personally signed and dated informed consent, indicating that the subject (or a legally recognized representative) has been informed of all pertinent aspects of the study
- Age ≥ 50 years
- No contra-indications for the use of the receiver in-the-ear device (BiometRIC SR 26UAA01GF), and smartwatch and chest strap heartrate monitor
You may not qualify if:
- Smokers
- Obese patients (BMI \>30 kg/m2)
- Presence of a pacemaker
- Supraventricular tachycardias: atrial fibrillation, atrial flutter, frequent supraventricular extrasystole or frequent ventricular extrasystole
- Otologic contraindications determined by licensed otolaryngologist
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Jessa Hospital
Hasselt, Limburg, 3500, Belgium
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
August 1, 2022
First Posted
August 3, 2022
Study Start
July 1, 2022
Primary Completion
October 1, 2022
Study Completion
December 1, 2022
Last Updated
August 4, 2022
Record last verified: 2022-08
Data Sharing
- IPD Sharing
- Will not share